Garry Arthur Neil, Global Head of R&D at MEDGENICS, INC. (MDGN), bought 24,390 shares at $4.10 ($100K) on 2014-12-01, disclosed to the SEC on 2014-12-02.
Open-market purchase of $100k MDGN by Global Head of R&D. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| AVTX | BUY | 2021-12-14 | $7K | — | Filing → |
| CERC | BUY | 2021-06-14 | $8K | — | Filing → |
| CERC | BUY | 2020-12-14 | $8K | — | Filing → |